Bright Minds Biosciences announced that Dr. Alan Kozikowski will no longer serve in the role of Chief Scientific Officer. Bright Minds has initiated a search for its new Chief Scientific Officer, and Jan Torleif Pedersen, PhD, MSc, a current member of the Board of Directors, will serve as the interim Chief Scientific Officer until the position is filled. Dr. Pedersen is an innovative and highly experienced leader in drug discovery research, with more than 25 years of expertise in neuroscience research management.

Dr. Pedersen spent 20 years at Lundbeck, a global pharmaceutical company specializing in brain diseases, in positions of increasing responsibility, including building its neurodegeneration/Alzheimer's disease pipeline and bringing research programs to the clinic.